Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis.

Skripconoka, Vija; Danilovits, Manfred; Pehme, Lea; Tomson, Tarmo; Skenders, Girts; Kummik, Tiina; Cirule, Andra; Leimane, Vaira; Kurve, Anu; Levina, Klavdia; Geiter, Lawrence J; Manissero, Davide; Wells, Charles D

Skripconoka, Vija; Danilovits, Manfred; Pehme, Lea; Tomson, Tarmo; Skenders, Girts; Kummik, Tiina; Cirule, Andra; Leimane, Vaira; Kurve, Anu; Levina, Klavdia; Geiter, Lawrence J; Manissero, Davide; Wells, Charles D.

Affiliation

Skripconoka V; Riga East University Hospital, Centre of Tuberculosis and Lung Diseases, Riga, Latvia.

Eur Respir J ; 41(6): 1393-400, 2013 Jun.

Article in En | MEDLINE | ID: mdl-23018916

Subject(s)

Antitubercular Agents/therapeutic use; Extensively Drug-Resistant Tuberculosis/drug therapy; Nitroimidazoles/therapeutic use; Oxazoles/therapeutic use; Tuberculosis, Multidrug-Resistant/drug therapy; Adolescent; Adult; Drug Administration Schedule; Extensively Drug-Resistant Tuberculosis/mortality; Female; Follow-Up Studies; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome; Tuberculosis, Multidrug-Resistant/mortality; Young Adult

Key words

Extensively drug-resistant; mycobacterium; pulmonary infection; treatment outcomes

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxazoles / Tuberculosis, Multidrug-Resistant / Extensively Drug-Resistant Tuberculosis / Nitroimidazoles / Antitubercular Agents Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Eur Respir J Year: 2013 Document type: Article Affiliation country: Latvia

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google